found a potential pathogenic amino acid substitution (Gly587Ser) in NLRP1, which was associated with increased production of pro‐inflammatory cytokines IL‐18 and IL‐1β in familial MS patients, as well as overall activation of the NLRP1‐mediated signaling pathway [36]. Here, NLRP1 is linked to myeloid sarcoma.